Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Recenti Progressi in Medicina|July 9, 2014
[Economic sustainability of therapies: considerations following the introduction of new drugs for hepatitis C virus]Federico Spandonaro
International Journal of Health Policy and Management|June 2, 2015
Regional incentives and patient cross-border mobility: evidence from the Italian experienceElenka Brenna, Federico Spandonaro
European Journal of Clinical Pharmacology|March 29, 2020
The implementation of health technology assessment principles in public decisions concerning orphan drugsElenka Brenna, Barbara Polistena, Federico Spandonaro
Evaluation and Program Planning|May 21, 2023
Analysing outpatient care access for planning purposes: The Basilicata Region experienceElenka Brenna, Barbara Polistena, Federico Spandonaro
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 4, 2021
The economic burden of obesity in Italy: a cost-of-illness studyMargherita d'Errico, Milena Pavlova, Federico Spandonaro
Le Infezioni in Medicina|March 16, 2020
Biosimilar pegfilgrastim and adherence to guidelines for chemotherapy-induced neutropenia and infections in cancer patientsMarco Danova, Andrea Antonuzzo, Federico Spandonaro, et al.
Giornale Italiano Di Cardiologia (2006)|April 29, 2014
[Acute heart failure clinical pathways, hospital funding and accreditation standards]Giorgio Carbone, Stefano Casciato, Federico Spandonaro, et al.
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Cost-effectiveness and budget impact of ivabradine in heart failure therapy]Barbara Polistena, Aldo Pietro Maggioni, Fabrizio Oliva, et al.
Acta Bio-Medica : Atenei Parmensis|August 31, 2022
Cost analysis of planned out-of-hospital births in ItalyRoberta Vittoria Cicero, Sofia Colaceci, Rosanna Amata, et al.
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[Prevalence of atrial fibrillation, treatment eligibility and consumption of oral anticoagulants in Italian Local Health Authorities: impact of non-vitamin K antagonist oral anticoagulants]Felicita Andreotti, Daniela D'Angela, R Letizia Mancusi, et al.
Pageof 5